Timing Baseline Marker A1c Why it matters Shows the longer-term blood sugar pattern that may matter during fat-loss or metabolic protocols
This multi-receptor approach distinguishes it from existing licensed medicines such as semaglutide (Ozempic, Wegovy) or tirzepatide licensed in the UK as Mounjaro for type 2 diabetes and as Zepbound for obesity which act on fewer receptor pathways
Check serum vitamin B12 levels, complete blood counts, and how the patient is doing regularly
Copper-Mediated Pathways: Research has explored its role as a copper-binding tripeptide in cellular signalling, antioxidant defence, and collagen-related biological models
#MindMattersPsychiatryWeightLoss #Psychiatry #HealthyLiving To view or add a comment, sign in Contrary to what some med-spas may suggest, medications arent miracle fixestheyre tools, and powerful ones, but only part of the bigger picture